Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

Ajovy Injection Approved for Migraine Prevention in Adults

Ajovy Injection Approved for Migraine Prevention in Adults

By

The primary efficacy endpoint was the mean change from baseline in the monthly average number of headache days of at least moderate severity during the 3-month treatment period.

FDA Approves Tiglutik for the Treatment of Amyotrophic Lateral Sclerosis

FDA Approves Tiglutik for the Treatment of Amyotrophic Lateral Sclerosis

By

The FDA approval was supported by data from bioavailability studies comparing riluzole tablets and Tiglutik oral suspension.

Sympazan Oral Film Granted Tentative Approval for Lennox-Gastaut Syndrome

Sympazan Oral Film Granted Tentative Approval for Lennox-Gastaut Syndrome

By

Clobazam is currently available as oral tablets and suspension under the trade name Onfi (Lundbeck).

TMS Device Cleared to Treat Obsessive Compulsive Disorder

TMS Device Cleared to Treat Obsessive Compulsive Disorder

By

Transcranial magnetic stimulation (TMS) uses magnetic fields to stimulate nerve cells in the brain.

Diacomit Approved for the Treatment of Dravet Sydrome

Diacomit Approved for the Treatment of Dravet Sydrome

By

Diacomit was evaluated in 2 multicenter, placebo-controlled, double-blind, randomized studies.

More Articles by Da Hee Han, PharmD

Sign Up for Free e-newsletters



CME Focus